IL151314A0 - Micelles, methods for their preparation and methods for delivery of micelles to patients - Google Patents

Micelles, methods for their preparation and methods for delivery of micelles to patients

Info

Publication number
IL151314A0
IL151314A0 IL15131401A IL15131401A IL151314A0 IL 151314 A0 IL151314 A0 IL 151314A0 IL 15131401 A IL15131401 A IL 15131401A IL 15131401 A IL15131401 A IL 15131401A IL 151314 A0 IL151314 A0 IL 151314A0
Authority
IL
Israel
Prior art keywords
micelles
methods
patients
delivery
preparation
Prior art date
Application number
IL15131401A
Other languages
English (en)
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of IL151314A0 publication Critical patent/IL151314A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL15131401A 2000-02-18 2001-02-20 Micelles, methods for their preparation and methods for delivery of micelles to patients IL151314A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18376800P 2000-02-18 2000-02-18
PCT/US2001/005297 WO2001060382A1 (en) 2000-02-18 2001-02-20 Micelles

Publications (1)

Publication Number Publication Date
IL151314A0 true IL151314A0 (en) 2003-04-10

Family

ID=22674206

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15131401A IL151314A0 (en) 2000-02-18 2001-02-20 Micelles, methods for their preparation and methods for delivery of micelles to patients
IL151314A IL151314A (en) 2000-02-18 2002-08-18 Cymbals, methods of preparation and programming and pharmaceutical preparations containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151314A IL151314A (en) 2000-02-18 2002-08-18 Cymbals, methods of preparation and programming and pharmaceutical preparations containing them

Country Status (10)

Country Link
US (3) US6906042B2 (de)
EP (2) EP1274443B1 (de)
JP (2) JP4959085B2 (de)
KR (1) KR100841813B1 (de)
AU (2) AU2001238507C9 (de)
CA (1) CA2400371C (de)
ES (1) ES2664818T3 (de)
HK (1) HK1052872A1 (de)
IL (2) IL151314A0 (de)
WO (1) WO2001060382A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
EP1274443B1 (de) * 2000-02-18 2017-05-10 Eisai R&D Management Co., Ltd. Mizellen
US7759323B2 (en) * 2001-05-22 2010-07-20 Eisai R & D Management Co., Ltd. Highly purified antiendotoxin compound
AU2002323106A1 (en) * 2001-08-10 2003-02-24 Eisai Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
WO2003082303A1 (en) * 2002-03-29 2003-10-09 Wisconsin Alumni Research Foundation Polymeric micelle formulations of hydrophobic compounds and methods
US20040116360A1 (en) * 2002-10-15 2004-06-17 Kwon Glen S. Encapsulation and deaggregation of polyene antibiotics using poly(ethylene glycol)-phospholipid micelles
EP1661556A4 (de) * 2003-08-20 2010-05-19 Ajinomoto Kk Medizinisches präparat mit verbesserten auflösungseigenschaften
WO2005088655A1 (en) * 2004-03-12 2005-09-22 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A magnetoresistive medium
CA2620027A1 (en) * 2005-08-31 2007-03-08 Eisai R & D Management Co., Ltd. Process for production of lipid a analogue
US20070178049A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
JP2009526858A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー コルチコステロイド溶液を製造する方法
TWI594755B (zh) 2012-03-28 2017-08-11 馬里蘭大學巴爾的摩校區 投予依立托倫或其醫藥上可接受的鹽以治療正黏液病毒感染
US11185554B2 (en) 2016-09-16 2021-11-30 Eisai R&D Management Co., Ltd Method of use of eritoran as a TLR4 antagonist for treatment of ebola and Marburg disease
BR112021010717A2 (pt) 2018-12-17 2021-08-31 Eisai R&D Management Co., Ltd. Formulação que compreende lipossomas
US11198831B2 (en) 2019-01-31 2021-12-14 Kvi Llc Lubricant for a device
WO2021207218A1 (en) 2020-04-06 2021-10-14 Eisai R&D Management Co., Ltd. Treatment of nidovirales infection with eritoran

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5681824A (en) 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US6417172B1 (en) 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
WO1997011708A1 (en) 1995-09-29 1997-04-03 Eisai Research Institute Method for treating alcoholic liver disease
JP4326030B2 (ja) * 1996-07-03 2009-09-02 エーザイ・アール・アンド・ディー・マネジメント株式会社 リピッドａ類縁体含有注射用製剤及びその製造方法
DK0909562T3 (da) 1996-07-03 2005-08-22 Eisai Co Ltd Injektionspræparat indeholdende en lipid A analog og fremgangsmåde til fremstilling deraf
US6495532B1 (en) * 1997-03-19 2002-12-17 Sky High, Llc Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
WO1998055106A1 (en) 1997-05-23 1998-12-10 Eisai Co., Ltd. Method for preparing pharmaceutical formulation
US6437006B1 (en) * 1999-09-27 2002-08-20 American Cyanamid Company Pharmaceutical carrier formulation
CA2392731A1 (en) 2000-01-14 2001-07-19 Eisai Co., Ltd. Prevention and treatment of endotoxemia and related complications associated with surgery
EP1274443B1 (de) * 2000-02-18 2017-05-10 Eisai R&D Management Co., Ltd. Mizellen
US6861512B2 (en) 2000-03-01 2005-03-01 Eisai Co., Ltd. Separation of olefinic isomers
US20030105033A1 (en) 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
JP4179881B2 (ja) 2000-12-06 2008-11-12 エーザイ株式会社 凍結乾燥ケークの抵抗を測定するためのシステム及び方法
CA2446356C (en) * 2001-05-09 2012-07-10 The Regents Of The University Of Michigan Use of compositions for treating rosacea
US7727974B2 (en) 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
MXPA05009428A (es) 2003-03-05 2005-12-12 Eisai Co Ltd Composiciones y metodos para prevenir y tratar enfermedades relacionadas con endotoxinas.

Also Published As

Publication number Publication date
EP1274443B1 (de) 2017-05-10
EP2452684B1 (de) 2018-01-24
JP2003522797A (ja) 2003-07-29
US7390793B2 (en) 2008-06-24
US20030216331A1 (en) 2003-11-20
US6906042B2 (en) 2005-06-14
EP2452684A3 (de) 2012-10-03
CA2400371A1 (en) 2001-08-23
US20050181039A1 (en) 2005-08-18
HK1052872A1 (zh) 2003-10-03
WO2001060382A1 (en) 2001-08-23
JP2012116860A (ja) 2012-06-21
EP1274443A4 (de) 2008-12-31
CA2400371C (en) 2009-12-08
US20090136564A1 (en) 2009-05-28
US7989432B2 (en) 2011-08-02
KR100841813B1 (ko) 2008-06-26
JP4959085B2 (ja) 2012-06-20
ES2664818T3 (es) 2018-04-23
IL151314A (en) 2007-06-03
KR20030011774A (ko) 2003-02-11
EP1274443A1 (de) 2003-01-15
EP2452684A2 (de) 2012-05-16
AU2001238507B2 (en) 2004-04-22
AU2001238507C9 (en) 2005-07-07
AU2001238507C1 (en) 2005-02-24
AU3850701A (en) 2001-08-27

Similar Documents

Publication Publication Date Title
IL151314A0 (en) Micelles, methods for their preparation and methods for delivery of micelles to patients
HUP0300209A3 (en) Lipid nanocapsules, preparation method and use as medicine
IL156531A0 (en) Lipid nanoparticles, their preparation and pharmaceutical compositions containing them
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
HUP0401461A3 (en) Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
HUP0301121A3 (en) Topical pharmaceutical formulations and methods of treatment
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
HUP0303078A3 (en) Cyclic peptidies process for their preparation pharmaceutical compositions containing them and their use
IL153708A0 (en) Benzimidazole derivatives, preparation and therapeutic use thereof
HUP0301892A3 (en) Pharmaceutical compositions for treatment of sexual dysfunction and their preparation
HUP0301685A3 (en) New aporphine esters and their use in therapy, process for their preparation and pharmaceutical compositions containing them
HUP0302130A3 (en) Combination pharmaceutical compositions and process for their preparation
HUP0400548A3 (en) Use of combinations of iop-reducing active inoredient for preparation of pharmaceutical compositions available for treatment glaucoma
EP1181022A4 (de) Medizinische zusammensetzungen und verfahren zu deren herstellung
HUP0400926A3 (en) Lipid lowering new biphenylcarboxamides, process for their preparation and pharmaceutical compositions containing them
IL152479A0 (en) Pharmaceutical form of administration for peptides, methods for its production and use
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
IL149360A0 (en) Method and compositions for administering taxanes orally to human patients
HUP0303731A3 (en) Sulfonylguanidines and their use for preparation of pharmaceutical compositions
HUP0303977A3 (en) Procedure for the preparation of pure phosphatides and their use in the cosmetic, pharmaceutical nad alimentary fields
HUP0203627A3 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical compositions comprising them
HUP0302310A3 (en) Novel formulations of alpha-2,4-disulfophenyl-n-tert-butylnitrone and process for their preparation
HUP0303597A3 (en) Diposable vaginal cannula for the simultaneous administration of drugs in different forms
IL156532A0 (en) Lipid microparticles, their preparation and pharmaceutical compositions containing them
HUP0201731A2 (en) Tetradeca-8,10-dienals, the method of preparation thereof and their use as sexual attractans for leafminer moths

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed